----
Current ValuationThe current P/E ratio is 22.48, below the reasonable range, cheaper than 90.71% of the time in the past 5 years, and the industry ranks 21/173, the industry Median -0.92.
22.48xP/E
$91.93Stock price
$4.09Earnings per share
22.48xP/E
Stock price$91.93Earnings per share$4.09
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 26.45x
- Typical range
- 24.04x–29.19x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
013263952
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
MDTUSMedtronic | 22.48x | 25.38% | $117.59B |
SYKUSStryker | 29.07x | 52.89% | $108.40B |
BSXUSBoston Scientific | 17.29x | 36.31% | $63.53B |
RMDUSResmed | 22.22x | 11.53% | $33.84B |
GEHCUSGE HealthCare Tech | 15.41x | 2.63% | $30.60B |
PHGUSKoninklijke Philips Elect | 18.73x | 14.78% | $24.18B |
RYLPFUSKoninklijke Philips N.V. | 17.56x | -- | $22.67B |
STEUSSteris | 26.52x | 17.79% | $21.35B |
TRUMYUSTerumo | 20.01x | -- | $21.03B |
ZBHUSZimmer Biomet | 21.79x | 37.03% | $17.58B |
SNNUSSmith and Nephew | 18.33x | 42.74% | $11.64B |
GMEDUSGlobus Medical Inc | 19.12x | 6.02% | $10.24B |
PODDUSInsulet | 25.84x | 76.03% | $9.70B |
SSMXYUSSysmex | 28.03x | -- | $7.09B |
LIVNUSLivanova | 22.58x | 189.82% | $4.26B |
TMDXUSTransMedics | 17.87x | 71.90% | $2.71B |
INSPUSInspire Medical | 15.30x | 100.86% | $2.07B |
LMATUSLemaitre Vascular | 28.84x | 13.99% | $1.89B |
CNMDUSConmed | 24.05x | 156.95% | $1.36B |
TCMDUSTactile | 20.61x | 36.59% | $512.39M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
